These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice. Peake KB; Vance JE J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650 [TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1. Singhal A; Szente L; Hildreth JEK; Song B Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967 [TBL] [Abstract][Full Text] [Related]
4. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease. Tamura A; Yui N J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067 [TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream. Taylor AM; Liu B; Mari Y; Liu B; Repa JJ J Lipid Res; 2012 Nov; 53(11):2331-42. PubMed ID: 22892156 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease. Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436 [TBL] [Abstract][Full Text] [Related]
7. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132 [TBL] [Abstract][Full Text] [Related]
8. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571 [TBL] [Abstract][Full Text] [Related]
9. Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment. Feltes M; Gale SE; Moores S; Ory DS; Schaffer JE J Lipid Res; 2020 Mar; 61(3):403-412. PubMed ID: 31988149 [TBL] [Abstract][Full Text] [Related]
10. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics. Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149 [TBL] [Abstract][Full Text] [Related]
11. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Liu B; Turley SD; Burns DK; Miller AM; Repa JJ; Dietschy JM Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2377-82. PubMed ID: 19171898 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the sterol-trafficking defect in Niemann-Pick C disease. Sturley SL; Patterson MC; Pentchev P Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2093-4. PubMed ID: 19211789 [No Abstract] [Full Text] [Related]
13. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228 [TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C. Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767 [TBL] [Abstract][Full Text] [Related]
15. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease. Tamura A; Yui N J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063 [TBL] [Abstract][Full Text] [Related]
16. Cyclodextrins applied to the treatment of lysosomal storage disorders. Ishitsuka Y; Irie T; Matsuo M Adv Drug Deliv Rev; 2022 Dec; 191():114617. PubMed ID: 36356931 [TBL] [Abstract][Full Text] [Related]
17. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. Rosenbaum AI; Zhang G; Warren JD; Maxfield FR Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119 [TBL] [Abstract][Full Text] [Related]
18. Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C. Yamada Y; Ishitsuka Y; Kondo Y; Nakahara S; Nishiyama A; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kamei S; Shuto T; Kai H; Hayashino Y; Sugita M; Kikuchi T; Hirata F; Miwa T; Takeda H; Orita Y; Seki T; Ohta T; Kurauchi Y; Katsuki H; Matsuo M; Higaki K; Ohno K; Matsumoto S; Era T; Irie T Br J Pharmacol; 2021 Jul; 178(13):2727-2746. PubMed ID: 33782944 [TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Abi-Mosleh L; Infante RE; Radhakrishnan A; Goldstein JL; Brown MS Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19316-21. PubMed ID: 19884502 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells. Egele K; Samaddar S; Schneider N; Thompson D; Wenz G J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]